Citigroup
PMVP icon

Citigroup’s PMV Pharmaceuticals PMVP Stock Holding History

Citigroup’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.9K Hold
19,296
– – ﹤0.01% 5116
2026
Q1 		$23.9K Hold
19,296
– – ﹤0.01% 4773
2025
Q4 		$24.1K Sell
19,296
-1
-0% -$1 ﹤0.01% 4819
2025
Q3 		$27K Buy
19,297
+1
+0% +$1 ﹤0.01% 4710
2025
Q2 		$20.5K Sell
19,296
-14
-0.1% -$14 ﹤0.01% 5068
2025
Q1 		$21K Sell
19,310
-495,601
-96% -$673K ﹤0.01% 5080
2024
Q4 		$778K Sell
514,911
-4
-0% -$6 ﹤0.01% 3543
2024
Q3 		$767K Sell
514,915
-714
-0.1% -$1.1K ﹤0.01% 3460
2024
Q2 		$835K Sell
515,629
-7,094
-1% -$12.8K ﹤0.01% 3036
2024
Q1 		$889K Buy
522,723
+2,116
+0.4% +$3.95K ﹤0.01% 3124
2023
Q4 		$1.61M Buy
520,607
+155,043
+42% +$410K ﹤0.01% 2427
2023
Q3 		$2.24M Buy
365,564
+301,244
+468% +$2.07M ﹤0.01% 1909
2023
Q2 		$403K Buy
64,320
+6,617
+11% +$34.7K ﹤0.01% 3520
2023
Q1 		$275K Sell
57,703
-58,343
-50% -$411K ﹤0.01% 3547
2022
Q4 		$1.01M Sell
116,046
-146,864
-56% -$1.57M ﹤0.01% 2598
2022
Q3 		$3.13M Sell
262,910
-258,145
-50% -$3.73M ﹤0.01% 1824
2022
Q2 		$7.42M Buy
521,055
+493,081
+1,763% +$7.18M 0.01% 1298
2022
Q1 		$582K Sell
27,974
-70,764
-72% -$1.25M ﹤0.01% 3404
2021
Q4 		$2.28M Buy
98,738
+44,853
+83% +$1.08M ﹤0.01% 2515
2021
Q3 		$1.61M Buy
53,885
+406
+0.8% +$13K ﹤0.01% 2711
2021
Q2 		$1.83M Buy
53,479
+20,459
+62% +$683K ﹤0.01% 2729
2021
Q1 		$1.09M Buy
33,020
+30,445
+1,182% +$1.2M ﹤0.01% 2919
2020
Q4 		$158K Buy
+2,575
New +$101K ﹤0.01% 5164

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Citigroup's PMVP Position: Q2 2026 in Review

Citigroup held its PMV Pharmaceuticals (PMVP) position steady in Q2 2026 at 19,296 shares worth $25.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5116.

Citigroup first reported a position in PMVP in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.42M in Q2 2022. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Citigroup held 19,296 shares of PMV Pharmaceuticals worth $25.9K as of Q2 2026.
  • Citigroup left its PMV Pharmaceuticals share count unchanged in Q2 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5116 holding.
  • Citigroup first reported a position in PMV Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Citigroup's PMV Pharmaceuticals position peaked at $7.42M in Q2 2022.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.